We are live on
!
Find out more
FGP
Freestone Grove Partners Portfolio holdings
AUM
$15.6B
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter
Est. Return
+0.81%
1 Year Est. Return
+27.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.2B
AUM Growth
+$326M
(+2.4%)
Cap. Flow
+$206M
Cap. Flow
% of AUM
1.46%
Top 10 Holdings %
Top 10 Hldgs %
19%
Holding
1,229
New
515
Increased
214
Reduced
228
Closed
267
Avg Time Held Equity + Options
1.1
quarters
Top 10 Avg Time Held Equity + Options
0.6
quarters
Top 20 Avg Time Held Equity + Options
0.4
quarters
Avg Time Held Equity only
1.1
quarters
Top 10 Avg Time Held Equity only
0.6
quarters
Top 20 Avg Time Held Equity only
0.4
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$134M |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$120M |
| 3 |
KKR & Co
KKR
|
+$113M |
| 4 |
Mondelez International
MDLZ
|
+$103M |
| 5 |
AXIS Capital
AXS
|
+$97.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$303M |
| 2 |
Boston Scientific
BSX
|
+$127M |
| 3 |
Lennar Class A
LEN
|
+$95.9M |
| 4 |
Martin Marietta Materials
MLM
|
+$94.6M |
| 5 |
Colgate-Palmolive
CL
|
+$92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.98% |
| 2 | Technology | 14.39% |
| 3 | Miscellaneous | 12.72% |
| 4 | Industrials | 12.27% |
| 5 | Healthcare | 11.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
Evommune Inc
EVMN
$213M
| $7.75M | 0.05% |
+337,291
| New | +$7.63M |
2026 Q1
0 quarters
|
|
302
TXNM Energy Inc
TXNM
$6.45B
| $7.71M | 0.05% |
131,813
-18,056
| -12% | -$1.06M |
2025 Q3
2 quarters
|
|
303
Solaris Energy Infrastructure
SEI
$5.12B
| $7.54M | 0.05% |
133,480
-79,660
| -37% | -$4.31M |
2025 Q3
2 quarters
|
|
304
Global Payments
GPN
$21.7B
| $7.35M | 0.05% |
109,259
+96,908
| +785% | +$7.15M |
2025 Q4
1 quarter
|
|
305
Bullish
BLSH
$4.82B
| $7.32M | 0.05% |
204,868
-64,147
| -24% | -$2.25M |
2025 Q3
2 quarters
|
|
306
Pool Corp
POOL
$5.84B
| $7.3M | 0.05% |
36,087
+33,005
| +1,071% | +$7.78M |
2025 Q3
2 quarters
|
|
307
Applovin
APP
$91.1B
| $7.1M | 0.05% |
+17,844
| New | +$8.62M |
2026 Q1
0 quarters
|
|
308
Maze Therapeutics
MAZE
$1.48B
| $7.01M | 0.05% |
234,953
+116,077
| +98% | +$5.12M |
2025 Q4
1 quarter
|
|
309
Equity Lifestyle Properties
ELS
$11.4B
| $6.73M | 0.05% |
+107,742
| New | +$6.98M |
2026 Q1
0 quarters
|
|
310
Vornado Realty Trust
VNO
$6.32B
| $6.65M | 0.05% |
+255,951
| New | +$7.58M |
2026 Q1
0 quarters
|
|
311
Advanced Energy
AEIS
$11B
| $6.65M | 0.05% |
20,606
-36,925
| -64% | -$10.7M |
2025 Q3
2 quarters
|
|
312
Rollins
ROL
$15.5B
| $6.61M | 0.05% |
+123,674
| New | +$7.36M |
2026 Q1
0 quarters
|
|
313
MapLight Therapeutics
MPLT
$438M
| $6.38M | 0.05% |
313,957
+130,186
| +71% | +$2.33M |
2025 Q4
1 quarter
|
|
314
Lamb Weston
LW
$7.16B
| $6.34M | 0.04% |
+150,000
| New | +$6.69M |
2026 Q1
0 quarters
|
|
315
Array Technologies
ARRY
$550M
| $6.13M | 0.04% |
847,625
+112,478
| +15% | +$1.04M |
2025 Q4
1 quarter
|
|
316
Vera Therapeutics
VERA
$1.93B
| $5.88M | 0.04% |
+146,097
| New | +$6.29M |
2026 Q1
0 quarters
|
|
317
Sanmina
SANM
$11.4B
| $5.83M | 0.04% |
44,990
+16,077
| +56% | +$2.36M |
2025 Q4
1 quarter
|
|
318
UMB Financial
UMBF
$9.88B
| $5.66M | 0.04% |
+50,160
| New | +$6.04M |
2026 Q1
0 quarters
|
|
319
Lattice Semiconductor
LSCC
$17.2B
| $5.63M | 0.04% |
+60,694
| New | +$5.44M |
2026 Q1
0 quarters
|
|
320
Hinge Health
HNGE
$8.48B
| $5.4M | 0.04% |
+139,932
| New | +$5.82M |
2026 Q1
0 quarters
|
|
321
Shoals Technologies Group
SHLS
$1.46B
| $5.16M | 0.04% |
+784,559
| New | +$6.44M |
2026 Q1
0 quarters
|
|
322
United Parcel Service
UPS
$80.6B
| $4.93M | 0.03% |
+50,142
| New | +$5.38M |
2026 Q1
0 quarters
|
|
323
Hims & Hers Health
HIMS
$6.93B
| $4.77M | 0.03% |
+229,723
| New | +$5.43M |
2026 Q1
0 quarters
|
|
324
Itron
ITRI
$3.79B
| $4.75M | 0.03% |
53,016
+39,866
| +303% | +$3.83M |
2025 Q2
3 quarters
|
|
325
Janus Living Inc
JAN
$6.76B
| $4.71M | 0.03% |
+200,000
| New | +$4.69M |
2026 Q1
0 quarters
|
|
Similar funds
ECM
MIFH
GF
AIM
OTPPB
AA
IWC
Freestone Grove Partners's Q1 2026 Portfolio in Review
As of Q1 2026, Freestone Grove Partners held 1,229 positions worth $14.2B, up 2.4% from $13.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Freestone Grove Partners's Q1 2026 filing shows 515 new, 214 increased, 228 reduced and 267 closed positions. Its largest new stake was Citigroup: 1,180,436 shares worth $134M. The largest sale was iShares Core S&P 500 ETF, an estimated $303M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Miscellaneous.
- Freestone Grove Partners's largest Q1 2026 buy was Citigroup: 1,180,436 shares worth $134M.
- Freestone Grove Partners added most to AXIS Capital in Q1 2026, an estimated $97.1M increase.
- Freestone Grove Partners's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $303M.
- Freestone Grove Partners fully exited Boston Scientific in Q1 2026, selling an estimated $127M.
- Freestone Grove Partners's ten largest holdings make up 19% of its $14.2B portfolio in Q1 2026.
- Freestone Grove Partners opened 515 new positions and closed 267 in Q1 2026.
- Freestone Grove Partners's portfolio value rose 2.4% quarter-over-quarter to $14.2B.
Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.